摘要
目的探讨腹腔镜远端胃癌D2淋巴结清扫入路的可行性及安全性。方法回顾性分析山西省人民医院普通外科2010年3月至2011年7月行腹腔镜辅助胃癌D,根治性切除的54例远端胃癌患者的临床资料。全组术中淋巴结廓清入路均遵循“胃结肠韧带→横结肠系膜前叶→胰腺被膜→4sb→4d→6→14v和8a→12a→9→7→11p及1→3→5→网膜囊”的次序,分析该廓清入路的可行性及肿瘤手术学结果的有效性。结果54例患者手术时间(236±51)min,术中失血量(217±65)ml;近端切缘间距(4.5±2.4)cm,远端切缘距离(5.0±3.0)cm,标本切缘均阴性;淋巴结摘除数目(18±5)枚,阳性淋巴结平均0~14枚。术后胃管停留时间(5±2)d,尿管停留时间(2±1)d,术后进食时间(8±2)d,术后住院时间(15±4)d。随访(11±3)个月,局部复发死亡3例(5.6%)。结论规范的腹腔镜远端胃癌D2外科清入路安全可行,手术肿瘤学结果达到了远端、近端无瘤残余的要求。
Objectives To investigate the surgical approach, feasibility and surgical outcomes of laparascopic distal gastrectomy D2 (LDGD2). Methods Fifty-four patients who underwent LDGD2 were examined in terms of pathologic findings, operative outcomes,and complications. A simple and effective surgical procedure was as follows: gastrocolic ligament→transverse mesocolon anterior lobe→pancreatic capsule →4sb →4d →6 →qgv, 8a →12a →9 →7 → 11p, 1→3 →5 →lesser omental bursa. Efficacy and feasibility of this procedure was ana|yzed. Results The mean operative time was (236± 51) minutes, the mean number of lymph nodes was (18±5), the mean positive lymph nodes were 0- 14, the mean blood loss was (217±65) ml, and postoperative mean hospital stay was (15±4) days. Conclusions LDGD2 for lower and lower-middle gastric cancer is feasible and safe, and can meet the oncological demand.
出处
《中华胃肠外科杂志》
CAS
2012年第12期1269-1272,共4页
Chinese Journal of Gastrointestinal Surgery
关键词
胃肿瘤
腹腔镜
胃切除术
D2淋巴结清扫
Stomach neoplasms
Laparoscopy
Gastrectomy
D2 Lymphadenectomy